|
|
Improving Recognition, Assessment and Management of Tardive Dyskinesia
|
|
Facebook
LinkedIn
E-Mail
|
(1761)
|
Released: 10/08/2021
Expires: 03/31/2023 (subject to change)
- CE for this activity will not be available after this date.
Delivery Note: The content for this activity is available in multiple delivery formats (OnDemand Video and Publication) in the AANP CE Center. Learners completing this activity should only complete ONE delivery-method to earn credit. Completing multiple delivery options for the same activity is duplicate credit for the same content and may not be accepted by some regulatory bodies.
Click here if you would like to take the Publication content instead.
|
Overview
Tardive dyskinesia (TD) is a serious side effect that may occur with some medications used to treat mental illness. It is characterized as involuntary movements of the tongue, lips, face, trunk or extremities. Because TD may become a permanent condition if not detected early, a thorough understanding of TD pathophysiology and risk and recognition of the comprehensive array of signs and symptoms manifested in TD is critical for supporting patients with TD. Nurse practitioners in primary care and psychiatry who care for patients treated with antipsychotic drugs need to be aware of the potentiality of TD developing and stay vigilant in monitoring patients in their care.
Objectives
- Recognize the symptoms and impact of tardive dyskinesia (TD).
- Describe hyperkinetic movement disorders.
- Identify TD based on appropriate examinations and assessments.
- Develop management strategies to improve outcomes for patients with TD.
Speakers
Sattaria S. Dilks, DNP, APRN, PMHNP-BC, FAANP
Disclosure
This program was planned in accordance with AANP CE Standards and Policies.
Sattaria Dilks has the following disclosures: - Speaker - Otsuka/Lundbeck - long-acting injectables
All Planners involved in this activity have no relevant financial relationships to disclose.
Planners: Michele L. McKay, MSN, APRN, FNP-C, CHCP (AANP Education Specialist), Jessica Martin, Rachel Brown
Dr. Dilks does intend to discuss off-label uses of drugs approved by the US Food and Drug Administration (FDA) for use in the United States.Funded by an independent medical education grant from Neurocrine Biosciences.
Disclaimer
Individuals who have contributed to the CE Center were carefully selected for their knowledge and experience in the subject area under review. This presentation is informational only and may contain opinions of the authors from their personal experience that do not necessarily express the opinions of the American Association of Nurse Practitioners (AANP). The activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Clinical practice is a constantly changing process and new information becomes available every day. Neither AANP nor the contributing individuals can warrant that the material will continue to be accurate, nor do they warrant that the material is completely free of errors upon publication. Attendees and participants should appraise the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this program.
CE Credit Instructions- Read this activity description, including objectives and disclosures.
- Complete the Pretest associated to the activity.
- Complete the educational content:
- Video Presentations: Click the Play button to watch the activity presentation. Full participation credit for the activity will be received once the entire video has been watched.
- Click on the Additional Resources button to review all additional materials provided (handouts, post-test reviews, any other downloadable resources).
- After completing all content, click on the blue Next Steps button:
- Complete the post-test.
- Submit the evaluation to receive full AANP CE/Rx credit.
Additional Information
For questions or more information concerning this online CE opportunity contact the AANP CE Center Support team at CECenter@aanp.org.
1.35 Contact Hour(s) of CE,
0.25 of which may be applied towards Pharmacology
|
|
|
|
Adding Registration, Please wait...
